Yes ... what a sad state of affairs as the officeholders of Starpharma sit silently at HQ leaving the market wondering just what was meant by the "hard decisions" comment in the Quarterly and of course them leaving out AstraZeneca / Chase Sun from the main CEO comments in same
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-52
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
-0.006(5.71%) |
Mkt cap ! $41.39M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 9.9¢ | $23.28K | 232.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25000 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 183364 | 5 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |